Equinox Pharma Ltd.
Equinox Pharma provides computational drug discovery that identifies novel small-molecule candidates from large libraries using logic-based machine learning. It applies its proprietary INDDEx™ platform, built on a patented SV-ILP method, to learn quantitative logic rules from active and inactive screening data and perform ligand-based virtual screening. The platform combines chemoinformatics and rule-based models to highlight stereochemical and structural determinants of activity and enable scaffold-hopping. Equinox operates as a B2B drug discovery partner for pharmaceutical, agrochemical, biotech companies and medicinal-chemistry CROs, screening commercial or proprietary compound collections. Its technology is positioned to accelerate lead discovery and uncover novel chemotypes beyond close analogs of training molecules.
Equinox Pharma Ltd.
Equinox Pharma provides computational drug discovery that identifies novel small-molecule candidates from large libraries using logic-based machine learning. It applies its proprietary INDDEx™ platform, built on a patented SV-ILP method, to learn quantitative logic rules from active and inactive screening data and perform ligand-based virtual screening. The platform combines chemoinformatics and rule-based models to highlight stereochemical and structural determinants of activity and enable scaffold-hopping. Equinox operates as a B2B drug discovery partner for pharmaceutical, agrochemical, biotech companies and medicinal-chemistry CROs, screening commercial or proprietary compound collections. Its technology is positioned to accelerate lead discovery and uncover novel chemotypes beyond close analogs of training molecules.